N. Krug (Hannover, Germany), I. Hall (Nottingham, United Kingdom)
Introduction: pharmacogenetic approaches in the treatment of asthma I. P. Hall (Nottingham, United Kingdom)
| |
Viral infection in asthma exacerbations: role of interferon lambda M. Contoli, V. Laza-Stanca, P. Wark, M. Edwards, C. Hewson, S. Holgate, D. Davies, S. Kotenko, A. Papi, S. Johnston (Southampton, London, United Kingdom; Ferrara, Italy; , ; New Jersey, United States Of America)
| |
New phenotyping of corticosteroid-resistant asthma based on molecular mechanisms N. Mercado, Y. To, M. Ito, I. M. Adcock, P. J. Barnes, K. Ito (London, United Kingdom)
| |
Rates of asthma exacerbations are not affected by beta2-adrenergic receptor genotype in patients with persistent asthma P. M. Dorinsky, S. W. Yancey, L. D. Edwards, L. B. Sutton, H. G. Ortega (Research Triangle Park, United States Of America)
| |
Association of genetic variations of CC chemokine receptor-2 (CCR2) with atopic asthma, but not with nonatopic asthma H. W. Park, S. H. Kim, S. W. Son, K. M. Kim, C. H. Park, H. K. Kim, Y. K. Kim, S. H. Cho, K. U. Min, Y. Y. Kim (Seoul, Republic Of Korea)
| |
Effect of increased protein glycosylation on the development of severe "irreversible" asthma I. V. Liverko (Tashkent, Uzbekistan)
| |
Polymorphisms of the IL-4 and IL-4 receptor alpha chain genes and bronchial asthma T. E. Gembitskaya, N. A. Kelembet, T. E. Ivaschenko (St. Petersburg, Russian Federation)
| |
GSTM1, GSTT1 polymorphisms, chronic allergic rhinitis and risk of asthma: a case-control study in Ukrainian population M. Ebrahimi, S. V. Podolskaya, N. G. Gorovenko (Kiev, Ukraine)
| |